Senate Health Panel Presses Hahn About Drug Pricing, Biologics, Vaping

By Kelly Lienhard / November 20, 2019 at 7:13 PM
During the Senate health committee’s confirmation hearing for FDA commissioner-nominee Stephen Hahn on Wednesday (Nov. 20), lawmakers grilled the nominee on myriad issues, including drug pricing, generic drug approvals, drug shortages and e-cigarette regulations. Hahn, who is currently chief medical executive of MD Anderson Cancer Center, continuously promised lawmakers he would look into the issues and work with them to push certain efforts forward. Senate health committee Chair Lamar Alexander (R-TN) lauded Hahn’s distinguished background and said he’s eager to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.